Home/The Egyptian Journal of Forensic Sciences and Applied Toxicology/Article Record
Peer-Reviewed Article November 30, 2019

Early L-carnitine Therapy in Severe Acute Aluminum Phosphide Poisoning: A Randomized Controlled Clinical Trial

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: The Egyptian Journal of Forensic Sciences and Applied Toxicology
Publisher: Cairo University, Faculty of Medicine, Forensic Medicine and Clinical Toxicology Department • Egypt • 1687-0875 • 2535-1915
DOI: https://doi.org/10.21608/ejfsat.2020.17184.1097

Abstract

Introduction: Aluminum phosphide (AlP) is a common solid fumigant pesticide used for agricultural and nonagricultural purposes. In Egypt, AlP tablets are frequently used to commit suicide, and AlP poisoning constituting a frequent cause of admission and mortality in poison control centers. Current management of AlP poisoning is limited to supportive care; as there is no specific antidote. Objectives: to evaluate the therapeutic effect and safety of early L-carnitine administration, as an antioxidant, in treatment of severe acute AlP poisoning. Material and methods: This study was a randomized controlled clinical trial. It was conducted in Tanta Poison Control center (Emergency Hospital, Tanta University). Fifty acute AlP intoxicated patients were randomly allocated into two equal groups A and B using the sequentially numbered, opaque sealed envelopes method. Group A received only the routine treatment. Group B received L – Carnitine therapy as follow: 9 ampoules (9 gm) of L- Carnitine in 500 ml of 0.9% normal saline given as continuous IV infusion, until improvement or death in addition to the routine treatment. Complete physical examination, routine laboratory investigations and oxidative stress markers; malondialdehyde (MDA), total antioxidant capacity (TAC) and reduced glutathione (GSH) were assessed for each patient. Results: Comparison between groups A and B 12 hrs after admission revealed significant reduction of the mean MDA levels in group B than group A (7.54± 1.74 and 16.22± 2.95 respectively, p<0.001). At the same time, group B showed significant elevation in the mean TAC (5.70±1.55 and 12.88±2.49 respectively) and GSH levels (2.37±.89, 4.09±.86 respectively). Additionally, the need for intubation and mechanical ventilation was significantly lower in group B compared to group A (20% versus 56 % respectively). However, there was non-significant reduction in the number of deaths in patients on L-carnitine therapy (group B) compared with group A (60% and 80% respectively, p >0.05). Conclusion: Early administration of L-carnitine IV infusion was effective and safe as an adjuvant treatment of AlP poisoned patients.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

13
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.